LYONDELLBASELL INDU-CL A (LYB) Fundamental Analysis & Valuation

NYSE:LYB • NL0009434992

Current stock price

79.08 USD
+1.36 (+1.75%)
Last:

This LYB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. LYB Profitability Analysis

1.1 Basic Checks

  • In the past year LYB was profitable.
  • LYB had a positive operating cash flow in the past year.
  • LYB had positive earnings in 4 of the past 5 years.
  • LYB had a positive operating cash flow in each of the past 5 years.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • The Return On Assets of LYB (-2.21%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -7.46%, LYB is doing worse than 61.45% of the companies in the same industry.
  • The Return On Invested Capital of LYB (2.51%) is worse than 60.24% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for LYB is in line with the industry average of 6.51%.
  • The last Return On Invested Capital (2.51%) for LYB is well below the 3 year average (6.66%), which needs to be investigated, but indicates that LYB had better years and this may not be a problem.
Industry RankSector Rank
ROA -2.21%
ROE -7.46%
ROIC 2.51%
ROA(3y)2.42%
ROA(5y)6.64%
ROE(3y)6.57%
ROE(5y)19.56%
ROIC(3y)6.66%
ROIC(5y)11.12%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • LYB's Operating Margin of 2.76% is on the low side compared to the rest of the industry. LYB is outperformed by 62.65% of its industry peers.
  • LYB's Operating Margin has declined in the last couple of years.
  • LYB's Gross Margin of 8.55% is on the low side compared to the rest of the industry. LYB is outperformed by 83.13% of its industry peers.
  • In the last couple of years the Gross Margin of LYB has declined.
Industry RankSector Rank
OM 2.76%
PM (TTM) N/A
GM 8.55%
OM growth 3Y-35.45%
OM growth 5Y-18.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-6.92%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

3

2. LYB Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LYB is destroying value.
  • LYB has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, LYB has less shares outstanding
  • Compared to 1 year ago, LYB has a worse debt to assets ratio.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.04 indicates that LYB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • LYB has a Altman-Z score of 2.04. This is comparable to the rest of the industry: LYB outperforms 54.22% of its industry peers.
  • The Debt to FCF ratio of LYB is 33.69, which is on the high side as it means it would take LYB, 33.69 years of fcf income to pay off all of its debts.
  • LYB has a Debt to FCF ratio of 33.69. This is comparable to the rest of the industry: LYB outperforms 43.37% of its industry peers.
  • LYB has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
  • LYB's Debt to Equity ratio of 1.22 is on the low side compared to the rest of the industry. LYB is outperformed by 71.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 33.69
Altman-Z 2.04
ROIC/WACC0.33
WACC7.65%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • LYB has a Current Ratio of 1.77. This is a normal value and indicates that LYB is financially healthy and should not expect problems in meeting its short term obligations.
  • LYB has a Current ratio (1.77) which is in line with its industry peers.
  • LYB has a Quick Ratio of 1.20. This is a normal value and indicates that LYB is financially healthy and should not expect problems in meeting its short term obligations.
  • LYB has a Quick ratio (1.20) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.2
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

3

3. LYB Growth Analysis

3.1 Past

  • The earnings per share for LYB have decreased strongly by -73.44% in the last year.
  • The earnings per share for LYB have been decreasing by -21.44% on average. This is quite bad
  • The Revenue for LYB has decreased by -25.18% in the past year. This is quite bad
  • LYB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.67% yearly.
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
Revenue 1Y (TTM)-25.18%
Revenue growth 3Y-15.77%
Revenue growth 5Y1.67%
Sales Q2Q%-25.33%

3.2 Future

  • The Earnings Per Share is expected to grow by 36.17% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, LYB will show a small growth in Revenue. The Revenue will grow by 1.26% on average per year.
EPS Next Y45.49%
EPS Next 2Y49.76%
EPS Next 3Y44.39%
EPS Next 5Y36.17%
Revenue Next Year0.36%
Revenue Next 2Y0.64%
Revenue Next 3Y0.9%
Revenue Next 5Y1.26%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

2

4. LYB Valuation Analysis

4.1 Price/Earnings Ratio

  • LYB is valuated quite expensively with a Price/Earnings ratio of 46.52.
  • 62.65% of the companies in the same industry are cheaper than LYB, based on the Price/Earnings ratio.
  • LYB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.23.
  • With a Price/Forward Earnings ratio of 31.97, LYB can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, LYB is valued a bit more expensive than the industry average as 61.45% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of LYB to the average of the S&P500 Index (22.51), we can say LYB is valued slightly more expensively.
Industry RankSector Rank
PE 46.52
Fwd PE 31.97
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as LYB.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as LYB.
Industry RankSector Rank
P/FCF 66.35
EV/EBITDA 15.45
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • LYB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as LYB's earnings are expected to grow with 44.39% in the coming years.
PEG (NY)1.02
PEG (5Y)N/A
EPS Next 2Y49.76%
EPS Next 3Y44.39%

5

5. LYB Dividend Analysis

5.1 Amount

  • LYB has a Yearly Dividend Yield of 3.70%. Purely for dividend investing, there may be better candidates out there.
  • LYB's Dividend Yield is rather good when compared to the industry average which is at 2.12. LYB pays more dividend than 86.75% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.90, LYB pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.7%

5.2 History

  • The dividend of LYB has a limited annual growth rate of 5.33%.
  • LYB has paid a dividend for at least 10 years, which is a reliable track record.
  • LYB has decreased its dividend recently.
Dividend Growth(5Y)5.33%
Div Incr Years1
Div Non Decr Years1
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

5.3 Sustainability

  • LYB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of LYB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-234.57%
EPS Next 2Y49.76%
EPS Next 3Y44.39%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

LYB Fundamentals: All Metrics, Ratios and Statistics

LYONDELLBASELL INDU-CL A

NYSE:LYB (3/27/2026, 11:59:05 AM)

79.08

+1.36 (+1.75%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-30
Earnings (Next)04-23
Inst Owners74.34%
Inst Owner Change2.63%
Ins Owners0.18%
Ins Owner Change0.52%
Market Cap25.48B
Revenue(TTM)30.15B
Net Income(TTM)-752.00M
Analysts52.14
Price Target52.2 (-33.99%)
Short Float %8.53%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 3.7%
Yearly Dividend5.46
Dividend Growth(5Y)5.33%
DP-234.57%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-137.75%
Min EPS beat(2)-299.66%
Max EPS beat(2)24.17%
EPS beat(4)1
Avg EPS beat(4)-80.58%
Min EPS beat(4)-299.66%
Max EPS beat(4)24.17%
EPS beat(8)3
Avg EPS beat(8)-39.32%
EPS beat(12)7
Avg EPS beat(12)-20.1%
EPS beat(16)10
Avg EPS beat(16)-15.37%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)3.26%
Max Revenue beat(2)3.27%
Revenue beat(4)4
Avg Revenue beat(4)2.27%
Min Revenue beat(4)0.76%
Max Revenue beat(4)3.27%
Revenue beat(8)7
Avg Revenue beat(8)1.06%
Revenue beat(12)8
Avg Revenue beat(12)0.1%
Revenue beat(16)10
Avg Revenue beat(16)0.24%
PT rev (1m)0.22%
PT rev (3m)-4.59%
EPS NQ rev (1m)10.82%
EPS NQ rev (3m)-69.55%
EPS NY rev (1m)-8.43%
EPS NY rev (3m)-31.28%
Revenue NQ rev (1m)1.05%
Revenue NQ rev (3m)0.49%
Revenue NY rev (1m)1.73%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 46.52
Fwd PE 31.97
P/S 0.84
P/FCF 66.35
P/OCF 11.26
P/B 2.53
P/tB 2.85
EV/EBITDA 15.45
EPS(TTM)1.7
EY2.15%
EPS(NY)2.47
Fwd EY3.13%
FCF(TTM)1.19
FCFY1.51%
OCF(TTM)7.02
OCFY8.88%
SpS93.59
BVpS31.29
TBVpS27.7
PEG (NY)1.02
PEG (5Y)N/A
Graham Number34.6
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -7.46%
ROCE 2.98%
ROIC 2.51%
ROICexc 2.86%
ROICexgc 3%
OM 2.76%
PM (TTM) N/A
GM 8.55%
FCFM 1.27%
ROA(3y)2.42%
ROA(5y)6.64%
ROE(3y)6.57%
ROE(5y)19.56%
ROIC(3y)6.66%
ROIC(5y)11.12%
ROICexc(3y)7.53%
ROICexc(5y)12.09%
ROICexgc(3y)8.19%
ROICexgc(5y)13.23%
ROCE(3y)7.89%
ROCE(5y)13.24%
ROICexgc growth 3Y-44.26%
ROICexgc growth 5Y-15.95%
ROICexc growth 3Y-43.41%
ROICexc growth 5Y-15.05%
OM growth 3Y-35.45%
OM growth 5Y-18.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-6.92%
F-Score3
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 33.69
Debt/EBITDA 5.56
Cap/Depr 135.11%
Cap/Sales 6.23%
Interest Coverage 1.72
Cash Conversion 101.85%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.2
Altman-Z 2.04
F-Score3
WACC7.65%
ROIC/WACC0.33
Cap/Depr(3y)118.58%
Cap/Depr(5y)129.11%
Cap/Sales(3y)5.44%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
EPS Next Y45.49%
EPS Next 2Y49.76%
EPS Next 3Y44.39%
EPS Next 5Y36.17%
Revenue 1Y (TTM)-25.18%
Revenue growth 3Y-15.77%
Revenue growth 5Y1.67%
Sales Q2Q%-25.33%
Revenue Next Year0.36%
Revenue Next 2Y0.64%
Revenue Next 3Y0.9%
Revenue Next 5Y1.26%
EBIT growth 1Y-69.96%
EBIT growth 3Y-45.63%
EBIT growth 5Y-17.24%
EBIT Next Year120.66%
EBIT Next 3Y44.31%
EBIT Next 5Y31.66%
FCF growth 1Y-80.61%
FCF growth 3Y-55.05%
FCF growth 5Y-23.41%
OCF growth 1Y-40.77%
OCF growth 3Y-28.23%
OCF growth 5Y-7.85%

LYONDELLBASELL INDU-CL A / LYB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LYONDELLBASELL INDU-CL A?

ChartMill assigns a fundamental rating of 3 / 10 to LYB.


What is the valuation status of LYONDELLBASELL INDU-CL A (LYB) stock?

ChartMill assigns a valuation rating of 2 / 10 to LYONDELLBASELL INDU-CL A (LYB). This can be considered as Overvalued.


How profitable is LYONDELLBASELL INDU-CL A (LYB) stock?

LYONDELLBASELL INDU-CL A (LYB) has a profitability rating of 3 / 10.


How financially healthy is LYONDELLBASELL INDU-CL A?

The financial health rating of LYONDELLBASELL INDU-CL A (LYB) is 3 / 10.


What is the earnings growth outlook for LYONDELLBASELL INDU-CL A?

The Earnings per Share (EPS) of LYONDELLBASELL INDU-CL A (LYB) is expected to grow by 45.49% in the next year.